Genvor Incorporated (OTCPK: GNVR)
Health Care · Biotechnology · US
$0.68
-24.17% today · -54.5% 1Y
Genvor Incorporated (OTCPK: GNVR) operates in the Biotechnology industry within the Health Care sector. The company is valued at $24.85M.
Over the last twelve months the share price has lost 54.5%, trading between 0.01 and 2.00.
Tweenvest scores Genvor Incorporated across four factors: quality 17/100, value 47/100. Its strongest factor is value.
GNVR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $24.85M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.10
- Dividend yield
- —
- Beta (5Y)
- 547,958.66
- 52-week high
- $2.00
- 52-week low
- $0.01
- Avg volume (3M)
- —
- Shares outstanding
- 36.41M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Genesystem Co., Ltd.KOSDAQ: A363250 | $25.76M | ₩4,145.00 | +1.97% |
| Kainos Medicine, Inc.KOSDAQ: A284620 | $25.58M | ₩— | — |
| D. Western Therapeutics Institute, Inc.TSE: 4576 | $25.15M | ¥69.00 | -1.43% |
| Immutep LimitedASX: IMM | $24.85M | AU$0.02 | +4.35% |
| Thiogenesis Therapeutics, Corp.TSXV: TTI | $24.74M | CA$0.50 | -5.66% |
| Seres Therapeutics, Inc.NasdaqGS: MCRB | $24.71M | $2.46 | -9.23% |
| Lukas Biomedical Inc.TPEX: 6814 | $24.52M | NT$19.00 | +2.70% |
| Original BioMedicals Co., Ltd.TPEX: 6483 | $24.50M | NT$11.90 | +3.93% |
Figures last refreshed Oct 18, 2026.